An exciting opportunity to perform cutting-edge basic and translational research.
Located at the foothills of the San Gabriel Mountains in beautiful Pasadena, HMRI offers a vibrant multi-disciplinary research environment with state-of-the-art facilities, in close collaboration with Caltech and Keck School of Medicine of University of Southern California (USC). The mission of our postdoctoral program is to train and inspire the next generation of independent researchers, through innovative projects, new technologies, collaborations, networking and high-impact publications. We are seeking highly creative and enthusiastic candidates to investigate scientific questions underlying major health concerns of national importance. If you are determined to discover, create, and develop breakthrough therapies in biomedical research, you are ready for HMRI.
Applicants must select and apply for one of the following programs based on research interests, expertise and career trajectory:
1) Aging and Alzheimer’s disease (AD) Research (Scientific Director: Dr. Michael Harrington): The project will investigate new mechanisms underlying the early stages of neurodegeneration associated with aging and AD. New tests to predict or detect early AD will be designed. The ideal candidate will have a strong background in neuroscience or cell biology, with experience in cellular/subcellular fractionation, western blot, immunoassay, and chromatography/mass spectrometry techniques. An interest in neurodegeneration will be highly valued.
2) Migraine Research (Scientific Director: Dr. Michael Harrington): Migraine is among the top 5 leading causes of “years lived with disability”. The project will explore new fundamental mechanisms as to why and when a migraine starts and develop new treatment strategies. Studies will be conducted in animal models and patients. The ideal candidate will have a strong background in neuroscience, and expertise in rodent behavioral models, cell culture, immunohistochemical labeling, and gene expression techniques will be preferred.
3) Human Brain-Heart Imaging Research (Clinical and Scientific Director: Dr. Kevin King): The project will develop novel noninvasive MR-based assays, biomarkers and imaging methodology to gain new insights into the dynamic interplay between the brain and the heart, and disease related aberrations. Information will be combined to uncover novel biological and physiological correlates of brain-heart physiology and pathophysiology. Candidates with a background in vascular biology, neurocardiology or radiology and expertise in using MRI will be preferred.
4) Cardiovascular Research (Chief Science Officer and Scientific Director: Dr. Robert Kloner): The project will investigate new mechanisms and models in heart failure and cardiogenic shock and generate novel approaches to reduce cell death during heart attack. New pharmacologic therapies that protect the mitochondria during ischemia/reperfusion are a recent focus of the laboratory. In addition, the acute and chronic effects of the now popular electronic cigarette smoke or vaping on the cardiovascular system in normal young versus old hearts, as well as hearts with underlying heart disease will be carefully examined. Furthermore, the effect of pure nicotine on the heart will be studied. Candidates with a background in vascular and myocardial biology will be preferred. Experience in molecular and cell biology techniques, biochemistry, bioinformatics, and murine cardiac models are all considered strengths for this position.
5) Neuropsychiatric Disease Research (Scientific Director: Dr. Anju Vasudevan): Dr. Vasudevan is currently relocating her laboratory from McLean Hospital/Harvard Medical School to HMRI (http://www.theabdl.org/). The project will investigate novel mechanisms underlying cell-autonomous programs that regulate endothelial and neuronal cell development in the forebrain, and uncover new causes for the origin of neuropsychiatric diseases like schizophrenia, autism, epilepsy and depression. The project will tap into the potential of CNS angiogenesis as a therapeutic source for recovery of neurological function in many diverse scenarios. The ideal candidate will have a relevant background either in neuroscience, developmental biology or cell biology with experience in endothelial cell culture, transgenic mouse models or stem cell biology.
Applicants must have completed a PhD, an MD, or an MD, PhD program and may have no more than five years of research training or experience since obtaining a doctoral-level degree.
STIPEND AND RESOURCES:
The initial appointment will be for two years with the possibility of extension. Salary is determined based on MD/PhD receipt date according to a set salary schedule, which begins at $54,080.00 up to a maximum of $59,000.00 plus benefits. Postdoctoral fellows will also receive up to $2,500 annually to support computing, travel and research needs.
|Number of Years||Average Annual Salary|
|Less than 1 year||$54,080.00|
APPLICATION AND PROCESS:
Applications are accepted through http://bit.ly/HMRIpostdocapp.
Application materials should include a cover letter with a brief summary of career goals and objectives, CV, copies of published abstracts or papers and three letters of recommendation. Private letters of recommendation can be submitted using this form: http://bit.ly/postdocletter
Review of applications will begin immediately and continue until the positions are filled.
HMRI provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.